Beyond LDL-C: Atherogenic Lipoproteins and CVD Risk
At @UCSFSchoolofMedicine Ronald Krauss, MD, focuses on plasma lipoprotein metabolism and related traits that influence risk for coronary artery disease.
▶︎
Update on ASCVD Risk Assessment and Management
▶︎
Coronary Artery Calcium: Finally Endorsed in Major Guidelines - An Early 2022 Update
▶︎
Dr. Ron Krauss - Diet, Adiposity, and Atherogenic Dyslipidemia
▶︎
Understand Your CHOLESTEROL PANEL & Metabolic Health Tests - The ULTIMATE Guide | Dr. Robert Lustig
▶︎
Lp(a) Explained: Genetics, Risk, and What You Can Actually Do
▶︎
Grand Rounds - Dr Tom Dayspring 9/24/20
▶︎
Metabolism | Lipoprotein Metabolism | Chylomicrons, VLDL, IDL, LDL, & HDL
▶︎
Update on Triglycerides
▶︎
How to Prevent Heart Disease (Atherosclerosis Explained)
▶︎
Dr. David Diamond - 'Should You Be Concerned About High LDL-Cholesterol on a Low Carb Diet?'
▶︎
Martin Wiedmann and colleagues | Balancing food safety and sustainability
▶︎
Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference
▶︎
The Cholesterol Controversy | Dr Paul Mason x Dr Peter Brukner
▶︎
Residual cardiovascular risk. What is the role of icosapent ethyl?
▶︎
2020 FH Global Summit Session 4: Lp(a) and Drivers of Inherited Risk
▶︎
Truth About Triglycerides
▶︎
Cardiology Grand Rounds - Donald M Lloyd-Jones, MD
▶︎
Triglyceride/HDL Ratio - A Better CV Risk Predictor than LDL? (Part 1)
▶︎
How to eat to lower your cholesterol in 10 days | Prof. Sarah Berry
▶︎